Analysis of the Incidence of Expression of a Specific Set of Genes and of Tumor Antigens in Cancer Tissue From Patients With Hepatocellular Carcinoma
N/A
N/A
N/A
N/A
N/A
Not Enrolling
Both
Hepatocellular Carcinoma
Both
Hepatocellular Carcinoma
Trial Information
Analysis of the Incidence of Expression of a Specific Set of Genes and of Tumor Antigens in Cancer Tissue From Patients With Hepatocellular Carcinoma
Inclusion Criteria:
- The patient had pathologically proven hepatocellular carcinoma
- All the data required are available from patient's records
- A sufficient amount of RNA is available for all three tissue samples
Exclusion Criteria:
N/A
Type of Study:
Observational
Study Design:
Observational Model: Case-Only, Time Perspective: Retrospective
Outcome Measure:
This study will also analyze whether this gene-expression signature is present in matched cirrhotic tissue and the interface tissue with the tumor.
Outcome Time Frame:
At the time of analysis.
Safety Issue:
No
Principal Investigator
GSK Clinical Trials
Investigator Role:
Study Director
Investigator Affiliation:
GlaxoSmithKline
Authority:
Italy: Agenzia Italiana del Farmaco
Study ID:
111722
NCT ID:
NCT00858000
Start Date:
July 2009
Completion Date:
December 2009
Related Keywords:
- Hepatocellular Carcinoma
- markers
- expression analysis
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
